ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. — Investor Relations & Filings
Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and commercialization of biopharmaceutical products. The company focuses on genetic engineering, cell therapy, and precision medicine. Its core product portfolio includes recombinant human growth hormone (rhGH) marketed under the brand Ansomone, and recombinant human interferon alpha-2b known as Anterferon. Anke Bio also develops diagnostic reagents, including biochemical and molecular diagnostic kits, and provides services in the fields of oncology and reproductive health. The company maintains a strong emphasis on innovation through its dedicated R&D centers, aiming to provide advanced therapeutic solutions for growth disorders, viral infections, and various cancers. Its operations span the entire value chain from basic research to clinical application and market distribution.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年半年度报告 | 2025-08-21 | Chinese | |
| 2025年半年度报告摘要 | 2025-08-21 | Chinese | |
| 关于回购注销部分限制性股票减资暨通知债权人的公告 | 2025-08-21 | Chinese | |
| 2025年半年度非经营性资金占用及其他关联资金往来情况汇总表 | 2025-08-21 | Chinese | |
| 关于回购注销第三期限制性股票激励计划部分限制性股票的公告 | 2025-08-21 | Chinese | |
| 关于参股公司PA3-17注射液纳入拟突破性治疗品种的公告 | 2025-08-08 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 35332984 | 2025年半年度报告 | 2025-08-21 | Chinese | ||
| 35332872 | 2025年半年度报告摘要 | 2025-08-21 | Chinese | ||
| 35332846 | 关于回购注销部分限制性股票减资暨通知债权人的公告 | 2025-08-21 | Chinese | ||
| 35332835 | 2025年半年度非经营性资金占用及其他关联资金往来情况汇总表 | 2025-08-21 | Chinese | ||
| 35332825 | 关于回购注销第三期限制性股票激励计划部分限制性股票的公告 | 2025-08-21 | Chinese | ||
| 35332817 | 关于参股公司PA3-17注射液纳入拟突破性治疗品种的公告 | 2025-08-08 | Chinese | ||
| 35332807 | 关于第4期员工持股计划非交易过户完成的公告 | 2025-08-05 | Chinese | ||
| 35332785 | 安徽天禾律师事务所关于安徽安科生物工程（集团）股份有限公司2025年第二次临时股东大会之法律意见书 | 2025-07-28 | Chinese | ||
| 35332769 | 2025年第二次临时股东大会决议公告 | 2025-07-28 | Chinese | ||
| 35332754 | 安徽天禾律师事务所关于安徽安科生物工程（集团）股份有限公司第4期员工持股计划（草案）之法律意见书 | 2025-07-22 | Chinese | ||
| 35332745 | 安徽安科生物工程（集团）股份有限公司第4期员工持股计划管理办法 | 2025-07-10 | Chinese | ||
| 35332730 | 关于第八届董事会第二十次会议决议的公告 | 2025-07-10 | Chinese | ||
| 35332711 | 安徽安科生物工程（集团）股份有限公司第4期员工持股计划（草案）摘要 | 2025-07-10 | Chinese | ||
| 35332690 | 董事会关于公司第4期员工持股计划草案合规性说明 | 2025-07-10 | Chinese | ||
| 35332677 | 关于召开2025年第二次临时股东大会的通知 | 2025-07-10 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55035/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55035 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55035 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55035 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55035}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. (id: 55035)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.